A top European drug agency gave a green light to new plants in the Netherlands, Germany and Switzerland for AstraZeneca, Pfizer-BioNTech and Moderna vaccines.
Tag: Pfizer Inc
Pfizer Begins Testing Its Vaccine in Young Children
Other drug makers have begun similar trials of their Covid-19 vaccines. If they work in children younger than 12 as expected, it will be easier for the U.S. to reach herd immunity.
Why Supply Isn’t the Only Thing Stymying Europe’s Coronavirus Vaccine Rollout
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Hong Kong Suspends Pfizer-BioNTech Vaccine Use Over Packaging Defects
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
E.U. Will Curb Covid Vaccine Exports for 6 Weeks
The European Union presented new emergency rules that will most likely severely cut exports to Britain and other countries to ease supply shortages at home.
Rich Countries Signed Away a Chance to Vaccinate the World
Despite warnings, American and European officials gave up leverage that could have guaranteed access for billions of people. That risks prolonging the pandemic.
Where Europe Went Wrong in Its Vaccine Rollout, and Why
While Washington went into business with the drug companies, Europe was more fiscally conservative and trusted the free market.
Will Israel’s Strong Vaccination Campaign Give Netanyahu an Election Edge?
Prime Minister Benjamin Netanyahu is banking on voters crediting him for beating the pandemic. But many worry that the country’s reopening may be premature and politically driven.
Some Long Covid-19 Patients Feel Better After Vaccine Doses
It is too soon to tell whether the shots have a broad beneficial effect on patients with continuing issues, but scientists are intrigued and beginning to study the phenomenon.